Ironwood Pharmaceuticals (IRWD) Current Assets (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Current Assets data on file, last reported at $332.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 106.93% year-over-year to $332.3 million; the trailing twelve-month figure through Mar 2026 stood at $332.3 million (up 106.93% YoY), and the FY2025 full-year result was $274.2 million, up 50.34% from the prior year.
• Current Assets grew to $332.3 million in Q1 2026, from $274.2 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $866.4 million in Q1 2023 to a low of $160.6 million in Q1 2025.
• A 5-year average of $379.9 million and a median of $273.8 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets plunged 75.97% in 2024 and jumped 106.93% in 2026, its largest moves.
• Tracing IRWD's Current Assets over 5 years: stood at $780.6 million in 2022, then slumped by 70.12% to $233.3 million in 2023, then fell by 21.83% to $182.4 million in 2024, then soared by 50.34% to $274.2 million in 2025, then grew by 21.2% to $332.3 million in 2026.
• Business Quant data shows IRWD's Current Assets at $332.3 million in Q1 2026, $274.2 million in Q4 2025, and $273.8 million in Q3 2025.